RecruitingNCT04507997
Angelman Syndrome Natural History Study
Sponsor
Boston Children's Hospital
Enrollment
300 participants
Start Date
Aug 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
Eligibility
Inclusion Criteria1
- Molecular diagnosis of Angelman syndrome
Exclusion Criteria1
- Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04507997
Related Trials
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
NCT0691460936 locations
A Natural History Study of Angelman Syndrome
NCT074171371 location
Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome
NCT067377181 location
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
NCT0715725422 locations
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
NCT071818373 locations